相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。MiR-422a weakened breast cancer stem cells properties by targeting PLP2
Yanmei Zou et al.
CANCER BIOLOGY & THERAPY (2018)
MiR-301a-3p Suppresses Estrogen Signaling by Directly Inhibiting ESR1 in ERα Positive Breast Cancer
Sandra Lettlova et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
miR-433 inhibits breast cancer cell growth via the MAPK signaling pathway by targeting Rap1a
Tao Zhang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)
MicroRNA-335-5p and-3p synergize to inhibit estrogen receptor alpha expression and promote tamoxifen resistance
Elizabeth C. Martin et al.
FEBS LETTERS (2017)
Inhibition of miR-660-5p expression suppresses tumor development and metastasis in human breast cancer
Y. Shen et al.
GENETICS AND MOLECULAR RESEARCH (2017)
MicroRNAs in the prognosis of triple-negative breast cancer A systematic review and meta-analysis
Lingshuang Lu et al.
MEDICINE (2017)
MiR-376c-3p regulates the proliferation, invasion, migration, cell cycle and apoptosis of human oral squamous cancer cells by suppressing HOXB7
Kai Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Cell Type- and Tissue Context-dependent Nuclear Distribution of Human Ago2
Nishi R. Sharma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
miR-155 downregulates ErbB2 and suppresses ErbB2-induced malignant transformation of breast epithelial cells
X-H He et al.
ONCOGENE (2016)
Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer
Xiaodan Meng et al.
ONCOTARGET (2016)
Evaluation of expression profiles of microRNAs and two target genes, FOXO3a and RUNX2, effectively supports diagnostics and therapy predictions in breast cancer
D. Jurkovicova et al.
NEOPLASMA (2016)
The role of exosomes and exosomal shuttle microRNA in tumorigenesis and drug resistance
Lei Zhao et al.
CANCER LETTERS (2015)
Data Normalization Strategies for MicroRNA Quantification
Heidi Schwarzenbach et al.
CLINICAL CHEMISTRY (2015)
The clinical relevance of circulating, exosomal miRNAs as biomarkers for cancer
Heidi Schwarzenbach
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2015)
miR-365 overexpression promotes cell proliferation and invasion by targeting ADAMTS-1 in breast cancer
Min Li et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Aberrant plasma levels of circulating miR-16, miR-107, miR-130a and miR-146a are associated with lymph node metastasis and receptor status of breast cancer patients
Isabel Stückrath et al.
Oncotarget (2015)
MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer
Gloria Bertoli et al.
THERANOSTICS (2015)
Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)
G. von Minckwitz et al.
ANNALS OF ONCOLOGY (2014)
Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/β-catenin signaling
Fei Ma et al.
GENE (2014)
Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial
Gunter von Minckwitz et al.
LANCET ONCOLOGY (2014)
Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: A case control study
Annette R. Kodahl et al.
MOLECULAR ONCOLOGY (2014)
Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients
Corinna Eichelser et al.
ONCOTARGET (2014)
Prooncogenic Factors miR-23b and miR-27b Are Regulated by Her2/Neu, EGF, and TNF-α in Breast Cancer
Lianjin Jin et al.
CANCER RESEARCH (2013)
Serum circulating microRNA profiling for identification of potential breast cancer biomarkers
Fermin Mar-Aguilar et al.
DISEASE MARKERS (2013)
BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression
Aldo M. Roccaro et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Plasma MicroRNA Panel for Minimally Invasive Detection of Breast Cancer
Katarina Cuk et al.
PLOS ONE (2013)
Circulating nucleic acids as biomarkers in breast cancer
Heidi Schwarzenbach
BREAST CANCER RESEARCH (2013)
The multifaceted exosome: Biogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunities
Saumya Pant et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Horizontal transfer of microRNAs: molecular mechanisms and clinical applications
Xi Chen et al.
PROTEIN & CELL (2012)
Invasive Breast Cancer: Recognition of Molecular Subtypes
Johanna D. Strehl et al.
BREAST CARE (2011)
Vesicle transfer and cell fusion
T. Kevin Howcroft et al.
CANCER BIOLOGY & THERAPY (2011)
MicroRNA-301 Mediates Proliferation and Invasion in Human Breast Cancer
Wei Shi et al.
CANCER RESEARCH (2011)
Characterization of extracellular circulating microRNA
Andrey Turchinovich et al.
NUCLEIC ACIDS RESEARCH (2011)
miR-155, a Modulator of FOXO3a Protein Expression, Is Underexpressed and Cannot Be Upregulated by Stimulation of HOZOT, a Line of Multifunctional Treg
Mayuko Yamamoto et al.
PLOS ONE (2011)
Haemolysis during Sample Preparation Alters microRNA Content of Plasma
Michaela B. Kirschner et al.
PLOS ONE (2011)
Microvesicles as mediators of intercellular communication in cancer-the emerging science of cellular 'debris'
Tae Hoon Lee et al.
SEMINARS IN IMMUNOPATHOLOGY (2011)
MicroRNA-155 Regulates Cell Survival, Growth, and Chemosensitivity by Targeting FOXO3a in Breast Cancer
William Kong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
Exosomes: proteomic insights and diagnostic potential
Richard J. Simpson et al.
EXPERT REVIEW OF PROTEOMICS (2009)
Circulating microRNAs as stable blood-based markers for cancer detection
Patrick S. Mitchell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells
Hadi Valadi et al.
NATURE CELL BIOLOGY (2007)
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
GA Calin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
About the possible origin and mechanism of circulating DNA - Apoptosis and active DNA release
M Stroun et al.
CLINICA CHIMICA ACTA (2001)